Investor Walton Thomas Layton
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Walton Thomas Layton . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-02-14 13G VGG8959N1069 / Tottenham Acquisition I Limited 3,759,599 0
2022-02-14 13G VGG8959N1069 / Tottenham Acquisition I Limited 3,759,599 0
2022-02-14 13G PHGE / BiomX Inc. 5,512,846 0
2022-02-14 13G TNYA / Tenaya Therapeutics, Inc. 2,642,285 0
2022-02-14 13G FNCH / Finch Therapeutics Group, Inc. 3,487,168 0
2021-08-09 13G TNYA / Tenaya Therapeutics, Inc. 2,642,285
2021-08-09 13G PHGE / BiomX Inc. 5,512,846
2021-03-26 13G FNCH / Finch Therapeutics Group, Inc. 3,487,168
2021-01-15 13G VGG8959N1069 / Tottenham Acquisition I Limited 3,759,599